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Corticosteroid drugs became available for the treatment of bronchial asthma in 1952. Twenty years later the use of hydrocortisone in the treatment of status asthmaticus remains ill-defined, doses between 100 and 1,000 mg or more in the first 24 hours of therapy being advocated by some workers (Rees, 1967; Grant, 1966; Rebuck and Read, 1971) . In this study hydrocortisone was given in a predetermined manner. The amount required to treat an acute attack of status asthmaticus was compared with clinical stigmata of its severity. Measurements of respiratory function, including arterial blood gases and the initial plasma cortisol, were made. It was hoped that one or more of these signs might help to indicate how much hydrocortisone would be required for treatment. Special attention was given to the initial plasma cortisol level before treatment was begun to determine whether those with low levels required more exogenous steroid than patients capable of maintaining a high level from their own intrinsic adrenal function.
METHODS
Plasma cortisol was measured by the method of Mattingly (1962) , and the recommendations of the Medical Research Council Working Party (1971) were followed. Analyses were made using an Aminco SPF-125 spectrofluorimeter. A standard sample of plasma, Seronorm, was included with each batch of estimations.
In order to assess adrenal function, a short synacthen test was performed between 9.00 and 11.00 a.m. A venous blood sample for the basal cortisol level was taken and followed immediately by an intravenous injection of 250 ,ug of synthetic ACTH (Synacthen, Ciba). Further blood samples were taken 30 minutes and 60 minutes later.
In the first part of the study basal plasma cortisol was measured in 53 normal subjects (49-2±15-8 years of age) consisting of medical staff, laboratory workers, and a few convalescent patients with no history of chest or endocrine disease. Short synacthen tests were performed in 14 of these persons.
Basal plasma cortisol and a short synacthen test was measured in a group of 70 unselected patients with bronchial asthma (30 male and 40 female). These estimations were made during a clinically stable phase. Bronchial asthma has been defined as widespread narrowing of the airways which varies in severity over short periods of time (Ciba Foundation Guest Symposium, 1959) . All patients had a history of intermittent attacks of wheeze and breathlessness accompanied by a sharp fall in forced expiratory volume, which could be reversed by antispasmodics. Eleven patients (37-7±14-8 years of age) had received no previous steroid therapy, 15 patients (46-8±17-1 years of age) had had episodic courses of prednisolone but were not taking any form of steroid at the time of the synacthen test, and 44 patients were having continuous prednisolone, 28 (52-5±13-8 years of age) less than 10 mg daily, and 16 patients (51-1±9-6 years of age) consistently more than 10 mg prednisolone daily.
Plasma cortisol was measured in a group of patients (63-4±19-1 years of age) admitted to hospital under 567 Ruth M. Cayton and P. Howard the stress of an acute medical illness. Twenty-two patients (15 male and 7 female) suffering from nonrespiratory conditions such as myocardial infarction, diabetic ketoacidosis, and acute renal failure were studied.
In the second part of the study all patients admitted to hospital in status asthmaticus between July 1971 and July 1972 were investigated. Status asthmaticus was defined as an acute attack of wheeze and breathlessness of sufficient severity to immobilize the patient and make talking difficult. If after four hours there was no clinical improvement, judged by a reduction in the severity of breathlesness and a fall in pulse rate, a further injection of 200 mg of hydrocortisone was given after repeating measurements of plasma cortisol, FEV, FVC, and arterial blood gases. This procedure was repeated after a further four hours if there was still no clinical improvement, and at four-hourly intervals as necessary until improvement was apparent. Most patients improved after one or two injections, in which case further hydrocortisone was not administered until the first signs of relapse appeared, judged by an increase in breathlessness or rise in pulse rate. It was decided in advance that if at any time after the initial injection the patient's condition deteriorated, with a fall in Pao2 to less than 50 mmHg and a rise in Paco2 to more than 46 mmHg, he was transferred to the intensive care unit for assisted ventilation and taken out of the study. This never proved necessary and no patient was ventilated.
If the patient had been receiving prednisolone before admission to hospital, this was given again during the convalescent phase, when the clinical condition had been stable for some time and the patient was mobile. A short synacthen test was performed in the outpatient department several weeks after full recovery.
RESULTS
The 9.00 a.m. plasma cortisol for 53 normal subjects was 19-5 (±7-1) /iLg/100 ml, which is similar to other quoted values (Mattingly, 1962) . Figure 1 shows the results of short synacthen tests measured in normal persons and 70 asthmatic patients. The 9.00 a.m. basal cortisol level in normal persons is significantly higher than the value found both in asthmatic patients taking less than 10 mg prednisolone daily (t=4-14, P<0 001) and in those patients taking more than 10 mg prednisolone daily (t=4-21, P<0001). The 30-minute and 60-minute cortisol levels found in normal persons are higher than in asthmatic patients taking prednisolone continuously. These are highly significant in patients taking less than 10 mg prednisolone 50- FIG. 1. Short synacthen tests measured in normal subjects and asthmatic patients: 0 normal subject; V asthmaticno steroid therapy; * asthmatic-episodic steroid therapy; 0 asthmatic-continuous steroid therapy ( < 10 mg prednisolone daily); E asthmatic-continuous steroid therapy ( >10 mg prednisolone daily). One standard deviation from the mean is given.
Plasma cortisol and the use of hydrocortisone in the treatment of status asthmaticus daily at 30 minutes (t=6.12, P<O-001) and at the 60-minute level (t=5-6, P<0 001) and in patients on higher doses of prednisolone (30 minutes t=8-66, P<0001 and 60 minutes t=7-43, P<0001). Adrenal suppression as measured by the short synacthen test occurs in asthmatic patients on continuous treatment with prednisolone, irrespective of the dose.
There is a linear relationship (Fig. 2 ) between the 9.00 a.m. plasma cortisol and the increase in cortisol level 60 minutes after an injection of synacthen (r=0-49, t=506, P<0001). This suggests that the basal cortisol level reflects adrenal suppression and may be an indicator of the adrenal response to a physiological stress such as status asthmaticus. The Table gives details of the p during status asthmaticus. The ag each patient are given together v plasma cortisol and the best avail convalescence for arterial blood ga metric tests of respiratory functior also given for pulse, blood pressur possible, plasma cortisol, arterial FEVy.75, and FVC when the patient to hospital in status asthmaticus.
In Fig. 3 with status asthmaticus is compared with the cortisol level achieved 60 minutes after synacthen. The synacthen test was performed in these patients several weeks after full recovery. There is a highly significant relationship between these two groups of figures (r=0-539, t=3-2, P<0-001). A linear, though not quite significant, relationship has also been demonstrated between the admission plasma cortisol and the basal cortisol in the same patients.
The Fig. 4 . In the first group there is a ,atients studied wide range of values reaching a maximum of ,e and sex of 158 ug /100 ml in cardiogenic shock. The maximum vith the basal cortisol level recorded in status asthmaticus was [able figure in 50 ,g/ 100 ml. Many patients on continuous steroid Lses and spiro-treatment had admission levels of less than n. Figures are 10 ug/100 ml.
*e, and, where
The admission cortisol level was compared with blood gases, clinical signs of the severity of status asthmaticus. was admitted There was no significant relationship between the initial cortisol and pulse rate, FEV, FVC or Pao,. (Grant, 1966; Lancet, 1972) . Tai and Read (1967) (Rebuck and Read, 1971) . Large doses of the drug, up to 1,000 mg in the first 24 hours of therapy, are advocated by many workers (Rees, 1967; Grant, 1966; Rebuck and Read, 1971) . Patients receiving continuous steroid treatment are thought to be particularly vulnerable in status asthmaticus due to a failure to increase plasma cortisol as a result of adrenal suppression (Walsh and Grant, 1966 ; Treadwell, Savage, Sever, and Copeman, 1963) . The severity of adrenal suppression is related to the daily and total dose of prednisolone administered, duration of therapy, and individual variation (Carter and James, 1970) . Intravenous short synacthen tests revealed adrenal suppression in all patients on continuous daily corticosteroids. This was reflected in lower levels of plasma cortisol on admission to hospital in status asthmaticus than in patients with asthma who had never had steroids. Despite the low levels no effect on the clinical course or response to treatment was observed. Such patients did not require larger doses of hydrocortisone to treat the acute attack. Dwyer, Lazarus, and Hickie (1967) suggested that the plasma cortisol response to intravenous injection of hydrocortisone was less than normal in steroid-treated patients and that this reduced response was associated with a lack of clinical improvement. Our observations and data do not support this opinion nor have we any evidence to suggest that a patient with status asthmaticus will not respond to treatment until a specified cortisol level is achieved. Dwyer et al. (1967) mention 100 ,ug/100 ml and Collins, Harris, Clark, and Townsend (1970) 150 g,/ 100 ml as the minimum plasma cortisol necessary to achieve a therapeutic response.
Admission cortisol levels in status asthmaticus never reached levels as high as those seen in other types of stress. The discrepancy between plasma cortisol levels of 55 Ag/100 ml in status asthmaticus and 155 Ag/100 ml in cardiogenic shock, despite the latter being a terminal illness, suggest that different forms of stress might operate through different control mechanisms.
The severity of status asthmaticus judged by clinical signs and physiological measurement did not in any way indicate the pattern of response to treatment, which seemed to fall into four groups. Some patients required a single injection of aminophylline, and others one iniection of 200 mg of hydrocortisone. The third group required repeated hydrocortisone injections but at infrequent intervals of several days, while group four needed injections of hydrocortisone every three to four hours.
It has been suggested that in status asthmaticus uncontrolled mast-cell degranulation occurs and that mast-cell counts are low in the bronchi of patients dying from asthma (Connell, 1971) . Histamine, serotonin, prostaglandins, and slow-reacting substance of anaphylaxis (SRS-A) released from mast cells are thought to produce airways obstruction by a combination of bronchial smooth muscle contraction, glandular secretion, and oedema (Orange and Austen, 1971 Following death in status asthmaticus, characteristically, the lungs show gross overinflation, the
